Ex-vivo lung perfusion

Current Opinion in Organ Transplantation

Volumn 17, Issue 5, 2012, Pages 490-495

  Sanchez, Pablo G ^a   D'Ovidio, Frank ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

ex vivo lung assessment; lung organ reconditioning; lung transplantation

Indexed keywords

DONOR SELECTION; EX VIVO STUDY; HUMAN; LUNG INJURY; LUNG PERFUSION; LUNG TRANSPLANTATION; ORGAN DONOR; POSTOPERATIVE COMPLICATION; REPERFUSION INJURY; REVIEW;

HUMANS; LUNG; LUNG TRANSPLANTATION; ORGAN PRESERVATION; PERFUSION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84866418651     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328357f865     Document Type: Review

References (26)

1. Lama VN. Update in lung transplantation 2008. Am J Respir Crit Care Med 2009; 179:759-764.
2. Cypel M, Yeung JC, Keshavjee S. Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning. Clin Chest Med 2011; 32:233-244.
3. Lindstedt S, Eyjolfsson A, Koul B, et al. How to recondition ex vivo initially rejected donor lungs for clinical transplantation: clinical experience from Lund University Hospital. J Transplant 2011; 2011:1-7.
4. Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012; 31:274-281.
5. Aigner C, Slama A, Hotzenecker K, et al. Clinical ex vivo lung perfusionpushing the limits. Am J Transplant 2012; 12:1839-1847.
6. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364:1431-1440.
7. Lindstedt S, Hlebowicz J, Koul B, et al. Comparative outcome of double lung transplantation using conventional donor lungs and nonacceptable donor lungs reconditioned ex vivo. Interact Cardiovasc Thorac Surg 2011; 12:162-165.
8. Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a nonheartbeating donor. Lancet 2001; 357:825-829.
9. Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27:1319-1325.
10. Pierre AF, DeCampos KN, Liu M, et al. Rapid reperfusion causes stress failure in ischemic rat lungs. J Thorac Cardiovasc Surg 1998; 116:932-942. (Pubitemid 28553535)
11. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from nonheartbeating donors after functional assessment ex vivo. Ann Thorac Surg 2003; 76:244-252; discussion 252. (Pubitemid 36819750)
12. Sanchez PG, Bittle GJ, Burdorf L, et al. State of art: clinical ex vivo lung perfusion: rationale, current status, and future directions. J Heart Lung Transplant 2012; 31:339-348.
13. Valenza F, Rosso L, Pizzocri M, et al. The consumption of glucose during ex vivo lung perfusion correlates with lung edema. Transplant Proc 2011; 43:993-996.
14. Koike T, Yeung JC, Cypel M, et al. Kinetics of lactate metabolism during acellular normothermic ex vivo lung perfusion. J Heart Lung Transplant 2011;30:1312-1319.
15. Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009; 9:2262-2269.
16. Yamada T, Nakajima D, Sakamoto J, et al. 422 Reconditioning of lungs with pulmonary edema in ex vivo lung perfusion circuit. J Heart Lung Transplant 2011; 30 (4 Suppl.):S144.
17. Karamanou DM, Perry J, Walden HR, et al. 279: The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J Heart Lung Transplant 2010; 29 (2 Suppl.):S94.
18. Otani S, Oto T, Kakishita T, et al. Early effects of the ex vivo evaluation system on graft function after swine lung transplantation. Eur J Cardiothorac Surg 2011; 40:956-961.
19. Nakajima D, Chen F, Yamada T, et al. Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion. J Heart Lung Transplant 2012; 31:187-193.
20. Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from nonheart-beating donors. J Heart Lung Transplant 2007; 26:1054-1060. (Pubitemid 47494662)
21. Dong B, Egan T. 280: Post-mortem and ex-vivo carbon monoxide (CO) ventilation reduces ischemia-reperfusion injury (IRI) in rat lungs transplanted from Non-Heart-Beating Donors (NHBDs). J Heart Lung Transplant 2010; 29 (2 Suppl.):S95.
22. Dong BM, Abano JB, Egan TM. Nitric oxide ventilation of rat lungs from nonheart-beating donors improves posttransplant function. Am J Transplant 2009; 9:2707-2715.
23. Yeung JC, Wagnetz D, Cypel M, et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre and postlung transplantation in the pig. Mol Ther 2012; 20:1204-1211.
24. Emaminia A, Lapar DJ, Zhao Y, et al. Adenosine A(2A) agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg 2011; 92:1840-1846.
25. Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009; 106:16357-16362.
26. Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007; 83:2191-2194. (Pubitemid 46782652)